Allergic contact dermatitis caused by topical eye drops.
Spaeth
George L
GL
D000287:Administration, Topical; D000959:Antihypertensive Agents / Q000009:adverse effects*; D001762:Blepharitis / Q000139:chemically induced*; D000068438:Brimonidine Tartrate; D017449:Dermatitis, Allergic Contact / Q000209:etiology*; D004359:Drug Therapy, Combination; D005260:Female; D005902:Glaucoma, Open-Angle / Q000188:drug therapy; D006801:Humans; D000077338:Latanoprost; D008875:Middle Aged; D009883:Ophthalmic Solutions / Q000009:adverse effects*; D011461:Prostaglandins F, Synthetic / Q000009:adverse effects*; D011810:Quinoxalines / Q000009:adverse effects*
D000959:Antihypertensive Agents; D009883:Ophthalmic Solutions; D011461:Prostaglandins F, Synthetic; D011810:Quinoxalines; D000068438:Brimonidine Tartrate; D000077338:Latanoprost